FDA 21 CFR Part 11: FAQs

Explore & learn more

FDA 21 CFR Part 11: FAQs

FDA 21 CFR Part 11: FAQs

In March of 1997, FDA issued final part 11 regulations (21 CFR Part 11) that provide criteria for acceptance by FDA, under certain circumstances, of electronic records, electronic signatures, and handwritten signatures executed to electronic records as equivalent to paper records and handwritten signatures executed on paper. These regulations, which apply to all FDA program areas, were intended to permit the widest possible use of electronic technology, compatible with FDA’s responsibility to protect the public health.

This paper answers some of the most commonly asked questions regarding °B Connected, a monitoring solution developed by B Medical Systems, that generates electronic records and 21 CFR Part 11.

FDA 21 CFR Part 11: FAQs

Download your free copy

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

    Privacy Settings saved!
    Privacy Settings

    When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

    These cookies are necessary for the website to function and cannot be switched off in our systems.

    In order to use this website we use the following technically required cookies
    • wordpress_test_cookie
    • wordpress_logged_in_
    • wordpress_sec

    Decline all Services
    Accept all Services